Key result
Persistent proteinuria during follow-up in hypertensive patients was associated with a significantly higher risk of developing myocardial infarction compared to no proteinuria (HR 2.41; 95% CI 1.59-3.66).
Why the study?
Does proteinuria increase the risk of myocardial infarction in patients with hypertension?
Cohort (n=24,926)
Does proteinuria increase the risk of myocardial infarction in patients with hypertension?
Effect estimate: HR 2.41 (95% CI 1.59-3.66)
p-value: p=< 0.05
Changes in proteinuria, particularly persistent proteinuria, are strongly associated with an increased risk of myocardial infarction in hypertensive patients.
May warrant closer MI surveillance in hypertensive patients with persistent proteinuria; leaves open whether reduction alters outcomes.
OBJECTIVE: To assess whether changes in proteinuria are associated with the incidence of myocardial infarction (MI) in patients with hypertension. METHODS: The Kailuan study was a prospective longitudinal cohort study on cardiovascular risk factors and events. Hazard ratios with 95% confidence intervals (CIs) were calculated using Cox regression models. RESULTS: A total of 24 926 hypertensive patients (mean age: 55.2 ± 10.9 years) without previous MI were included. After a mean follow-up of 6.8 years, 382 (1.5%) individuals developed MI. Participants with proteinuria at baseline had a 60% higher risk for developing MI as compared with participants without proteinuria at baseline (hazard ratio: 1.60, 95% CI: 1.12-2.29) after adjusting for dyslipidemia, diabetes mellitus and other cardiovascular risk factors. Compared with participants without proteinuria, individuals with incident proteinuria or persistent proteinuria during the follow-up had 54 and 141% higher risks for developing MI, respectively (hazard ratio: 1.54, 95% CI: 1.14-2.09 and hazard ratio: 2.41, 95% CI: 1.59-3.66; all P < 0.05). CONCLUSION: Proteinuria is associated with an increased incidence of MI, but the association is likely to be underestimated if baseline measurements of proteinuria are used. Measures of changes in proteinuria, particular persistent proteinuria, are more likely to reflect the lifetime risk for MI.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2017) conducted a cohort in Hypertension (n=24,926). Incident or persistent proteinuria vs. No proteinuria was evaluated on Incidence of myocardial infarction (MI) (HR 2.41, 95% CI 1.59-3.66, p=< 0.05). Persistent proteinuria during follow-up in hypertensive patients was associated with a significantly higher risk of developing myocardial infarction compared to no proteinuria (HR 2.41; 95% CI 1.59-3.66).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: